Literature DB >> 7236463

Formalin infiltration of ductus arteriosus in cyanotic congenital heart disease.

J E Deanfield, P G Rees, C M Bull, M de Leval, J Stark, F J Macartney, J F Taylor.   

Abstract

Formalin infiltration of the ductus arteriosus was performed in 13 neonates with pulmonary atresia (three with ventricular septal defect, two with tricuspid atresia, and eight with intact ventricular septum, one of whom had Ebstein's anomaly) in an attempt to maintain duct patency. Nine patients had an additional retrograde pulmonary valvotomy and one a Blalock-Taussig shunt. The mean preoperative systemic PO2 was 31 mmHg and rose significantly to 46 mmHg after operation. However, the PO2 rose in only two of the four patients who had formalin infiltration alone. There were five early deaths and three had clinical evidence of duct closure. Four patients needed further surgery (systemic-pulmonary artery shunt) within eight days. Seven of eight surviving patients were shown to have a closed duct at repeat cardiac catheterisation (two to 13 months after operation). The eighth died before restudy. There were four late deaths, one following late reoperation and the other three within five months of early reoperation. These results suggest that formalin infiltration cannot ensure long-term duct patency. As short-term patency can be maintained more reliably by prostaglandin administration, we have abandoned the operation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7236463      PMCID: PMC482566          DOI: 10.1136/hrt.45.5.573

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  4 in total

1.  Maintaining patency of the ductus-arteriosus for palliation of cyanotic congenital cardiac malformations. The use of prostaglandin E1 and formaldehyde infiltration of the ductal wall.

Authors:  J Hatem; R M Sade; J K Upshur; A R Hohn
Journal:  Ann Surg       Date:  1980-07       Impact factor: 12.969

2.  Formalin infiltration of the ductus arteriosus. A method for palliation of infants with selected congenital cardiac lesions.

Authors:  A M Rudolph; M A Heymann; N Fishman; J B Lakier
Journal:  N Engl J Med       Date:  1975-06-12       Impact factor: 91.245

3.  Oral prostaglandin E2 in ductus-dependent pulmonary circulation.

Authors:  E D Silove; J Y Coe; M F Shiu; J D Brunt; A J Page; S P Singh; M D Mitchell
Journal:  Circulation       Date:  1981-03       Impact factor: 29.690

4.  Modified Blalock-Taussig shunt. Use of subclavian artery orifice as flow regulator in prosthetic systemic-pulmonary artery shunts.

Authors:  M R de Leval; R McKay; M Jones; J Stark; F J Macartney
Journal:  J Thorac Cardiovasc Surg       Date:  1981-01       Impact factor: 5.209

  4 in total
  1 in total

1.  Congenital heart disease in the neonate: results of surgical treatment.

Authors:  E L Bove; C Bull; J Stark; M de Leval; F J Macartney; J F Taylor
Journal:  Arch Dis Child       Date:  1983-02       Impact factor: 3.791

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.